Bionpharma Inc.
Bionpharma Inc. appears in FDA public data with 2 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0012-2025, Class I) was initiated on September 17, 2024.
Summary
- Total Recalls
- 2 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Known Names
bionpharma, bionpharma inc
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0012-2025 | Class I | Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc. | September 17, 2024 |
| D-1519-2019 | Class II | Clobazam Oral Suspension, 2.5 mg/mL, 120 mL bottle, Rx only, Distributed by: Bionpharma Inc., 600 Al | July 16, 2019 |